SGBI Financials 07/16/2014 19:13:09 Sangui BioTec

SGBI Financials 07/16/2014 19:13:09
Sangui BioTech International, Inc.
Period Ending Jun 30, 2013 Jun 30, 2012 Jun 30, 2011 Jun 30, 2010
Total Revenue 105 15 6 18
Cost of Revenue 11 3 7 8
Gross Profit 95 12 (1) 10
Operating Expenses
Research and Development 65 104 314 112
Sales, General and Admin. 1,273 3,617 1,429 918
Non-Recurring Items - - - 21
Other 1 1 1 2
Operating Income (1,244) (3,711) (1,745) (1,042)
Income From Continuing Operations
Add'l Income/Expense Items (1,015) 166 149 1
Earnings Before Interest and Tax (2,259) (3,545) (1,605) (1,041)
Interest Expense 5 - - -
Earnings Before Tax (2,264) (3,545) (1,605) (1,041)
Income Tax - - - -
Minority Interest (168) (53) (77) (68)
Equity Earnings Unconsolidated Subsidiary - - (9) -
Net Income Cont. Operations (2,095) (3,492) (1,536) (973)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (2,095) (3,492) (1,536) (973)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (2,095) (3,492) (1,527) (973)